文献速递消化道肿瘤与早癌消化内镜

结直肠癌家族史人群年龄特异性筛查间隔的成本效益

Cost Effectiveness of Age-Specific Screening Intervals for People With Family Histories of Colorectal Cancer.
PubMed 文献 · Gastroenterology · 2017-09-28

研究基于已发表数据确定不同年龄和一级亲属患病人数的结直肠癌相对风险,用微模拟筛查分析模型评估不同年龄范围和间隔的结肠镜筛查策略的成本与效果。结果显示,有1名患病一级亲属者从40岁起每3年筛查最具成本效益,若未发现腺瘤,筛查间隔可在45岁和55岁时分别逐渐延长至5年和7年。

要点

  • 有1名患病一级亲属者从40岁起每3年筛查最具成本效益。
  • 若未发现腺瘤,筛查间隔可在45岁和55岁时分别逐渐延长至5年和7年。
  • 一级亲属患病人数越多者应更早开始筛查且间隔更短,但若无异常发现可降低频率。

核心结论

  • 对于有结直肠癌家族史者,若连续多次筛查结肠镜阴性且家族中无新发结直肠癌病例,逐渐延长筛查间隔具有成本效益。

研究设计与样本

  • 基于已发表数据确定不同年龄和患病一级亲属人数的结直肠癌相对风险,并使用微模拟筛查分析模型估算不同年龄范围和间隔的结肠镜筛查策略的成本与效果。

主要发现

  • 对于有1名患病一级亲属者(占家族史人群的92%),从40岁起每3年筛查最具成本效益。
  • 若未发现腺瘤,筛查间隔可在45岁时逐渐延长至5年、在55岁时延长至7年。
  • 从成本效益角度看,一级亲属患病人数更多者应更早开始筛查且间隔更短,但若无异常发现可降低频率。

关键数值与推荐

  • 增量成本效益比低于每质量调整生命年100000美元的策略被认为具有成本效益。
  • 有1名患病一级亲属者:从40岁起每3年筛查;若无腺瘤,45岁时间隔延长至5年,55岁时延长至7年。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Relative risk of colorectal cancer (CRC) decreases with age among individuals with a family history of CRC. However, no screening recommendations specify less frequent screening with increasing age. We aimed to determine whether such a refinement would be cost effective. METHODS: We determined the relative risk for CRC for individuals based on age and number of affected first-degree relatives (FDRs) using data from publications. For each number of affected FDRs, we used the Microsimulation Screening Analysis model to estimate costs and effects of colonoscopy screening strategies with different age ranges and intervals. Screening was then optimized sequentially, starting with the youngest age group, and allowing the interval of screening to change at certain ages. Strategies with an incremental cost effectiveness ratio below $100,000 per quality-adjusted life year were considered cost effective. RESULTS: For people with 1 affected FDR (92% of those with a family history), screening every 3 years beginning at an age of 40 years is most cost effective. If no adenomas are found, the screening interval can gradually be extended to 5 and 7 years, at ages 45 and 55 years, respectively. From a cost-effectiveness perspective, individuals with more affected FDRs should start screening earlier and at shorter intervals. However, frequency can be reduced if no abnormalities are found. CONCLUSIONS: Using a microsimulation model, we found that for individuals with a family history of CRC, it is cost effective to gradually increase the screening interval if several subsequent screening colonoscopies have negative results and no new cases of CRC are found in family members.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Naber SK, Kuntz KM, Henrikson NB, et al. Cost Effectiveness of Age-Specific Screening Intervals for People With Family Histories of Colorectal Cancer. Gastroenterology. 2017. PMID: 28964749. doi:10.1053/j.gastro.2017.09.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。